NCT05692518View on ClinicalTrials.gov

MagDI Diversion Feasibility Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

August 20, 2024

Study Completion Date

August 31, 2025

Conditions
Type 2 DiabetesObesity
Interventions
DEVICE

MAGNET System, DI Bio-fragmentable

Anastomoses achieved by magnetic compression.

Trial Locations (1)

N.6

Innova Medical Center, Tbilisi

Sponsors
All Listed Sponsors
lead

GT Metabolic Solutions, Inc.

INDUSTRY

NCT05692518 - MagDI Diversion Feasibility Study | Biotech Hunter | Biotech Hunter